Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
about
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
description
scientific article published on 15 March 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2019
@uk
name
Clinical Characteristics of Os ...... ients with EGFR-T790M Mutation
@en
Clinical Characteristics of Os ...... ients with EGFR-T790M Mutation
@nl
type
label
Clinical Characteristics of Os ...... ients with EGFR-T790M Mutation
@en
Clinical Characteristics of Os ...... ients with EGFR-T790M Mutation
@nl
prefLabel
Clinical Characteristics of Os ...... ients with EGFR-T790M Mutation
@en
Clinical Characteristics of Os ...... ients with EGFR-T790M Mutation
@nl
P2093
P50
P356
P1433
P1476
Clinical Characteristics of Os ...... ients with EGFR-T790M Mutation
@en
P2093
Kazuki Hirose
Koichi Takayama
Naoko Okura
Nobuyo Tamiya
Osamu Hiranuma
Shinsuke Shiotsu
Yoshiko Kaneko
Yusuke Chihara
Yutaka Kubota
P356
10.3390/CANCERS11030365
P407
P577
2019-03-15T00:00:00Z